ATE218853T1 - Flüssige wässrige arzneimittel, die natriumalginat und kaliumhydrogencarbonat enthalten - Google Patents

Flüssige wässrige arzneimittel, die natriumalginat und kaliumhydrogencarbonat enthalten

Info

Publication number
ATE218853T1
ATE218853T1 AT96903090T AT96903090T ATE218853T1 AT E218853 T1 ATE218853 T1 AT E218853T1 AT 96903090 T AT96903090 T AT 96903090T AT 96903090 T AT96903090 T AT 96903090T AT E218853 T1 ATE218853 T1 AT E218853T1
Authority
AT
Austria
Prior art keywords
hydrogen carbonate
sodium alginate
potassium hydrogen
containing sodium
products containing
Prior art date
Application number
AT96903090T
Other languages
English (en)
Inventor
Paul Frederick Field
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10770811&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE218853(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Application granted granted Critical
Publication of ATE218853T1 publication Critical patent/ATE218853T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96903090T 1995-03-03 1996-02-16 Flüssige wässrige arzneimittel, die natriumalginat und kaliumhydrogencarbonat enthalten ATE218853T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9504599.3A GB9504599D0 (en) 1995-03-03 1995-03-03 Improvements in or relating to organic compositions
PCT/GB1996/000358 WO1996027368A1 (en) 1995-03-03 1996-02-16 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate

Publications (1)

Publication Number Publication Date
ATE218853T1 true ATE218853T1 (de) 2002-06-15

Family

ID=10770811

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96903090T ATE218853T1 (de) 1995-03-03 1996-02-16 Flüssige wässrige arzneimittel, die natriumalginat und kaliumhydrogencarbonat enthalten

Country Status (22)

Country Link
US (1) US5681827A (de)
EP (1) EP0813407B1 (de)
JP (1) JPH11501044A (de)
KR (1) KR19980702689A (de)
CN (1) CN1123337C (de)
AR (1) AR004168A1 (de)
AT (1) ATE218853T1 (de)
AU (1) AU696480B2 (de)
BR (2) BR9607679B8 (de)
CZ (1) CZ289386B6 (de)
DE (1) DE69621785T2 (de)
ES (1) ES2174054T3 (de)
GB (1) GB9504599D0 (de)
HK (1) HK1007957A1 (de)
HU (1) HUP9801414A3 (de)
NO (1) NO316207B1 (de)
NZ (1) NZ301749A (de)
PL (1) PL184245B1 (de)
PT (1) PT813407E (de)
TR (1) TR199700891T1 (de)
WO (1) WO1996027368A1 (de)
ZA (1) ZA961517B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6099871A (en) * 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
PL194696B1 (pl) * 1997-04-30 2007-06-29 Reckitt Benckiser Healthcare Kompozycja w stałej postaci dawkowania zawierająca alginiany
US6027715A (en) * 1998-03-02 2000-02-22 Pozuelo; Jose Composition and means for treating dry mouth
AU4759099A (en) * 1998-09-21 2000-03-23 Mcneil-Ppc, Inc. Heat stable antacid and antigas suspensions
JP3959192B2 (ja) * 1998-12-03 2007-08-15 株式会社大塚製薬工場 経管栄養食品
US6351665B1 (en) 1999-05-07 2002-02-26 Kenneth L Koch Method and apparatus for evaluating myoelectric signals and identifying artifact
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
JP5079713B2 (ja) * 2006-03-16 2012-11-21 グライコロジック リミテッド 満腹を誘発するための、好ましく加工されたデンプンを含む胃内ラフト組成物
CA2676058C (en) 2007-02-13 2017-02-07 S-Biotek Holding Aps Diet product comprising alginate
WO2008106646A2 (en) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Methods and formulations for topical gene therapy
KR100930809B1 (ko) * 2008-02-13 2009-12-09 (주)포테이토밸리 레드킹밸리 감자의 생즙 또는 전분을 유효성분으로함유하는 위염, 위궤양 및 십이지장궤양 예방 및 치료용약학조성물
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
KR20120108218A (ko) * 2011-03-23 2012-10-05 동아제약주식회사 위식도 역류질환 치료용 액상 타입 조성물
WO2013055251A1 (ru) * 2011-10-14 2013-04-18 Общество С Ограниченной Ответственностью "Цитонир" Пероральная фармацевтическая композиция для лечения воспалительных заболеваний желудочно-кишечного тракта
EP2806880B2 (de) * 2012-01-27 2020-04-22 Institute of Bioorganic Chemistry Pharmazeutische zusammensetzung als antireflux-medikament
US9636360B2 (en) 2012-09-18 2017-05-02 pH Science Holdings, Inc Method and composition for treating gastro-esophageal disorders
KR102303835B1 (ko) * 2014-01-08 2021-09-16 영진약품 주식회사 수성의 유동성 액체 조성물 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
US4869902A (en) * 1984-04-19 1989-09-26 Rorer Pharmaceutical Corporation Antacid composition
EP0179858B1 (de) * 1984-04-19 1992-07-01 Rhone-Poulenc Rorer International (Holdings) Inc. Antisäurezusammensetzung
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
JPH0482832A (ja) * 1988-09-20 1992-03-16 Glaxo Group Ltd 医薬組成物

Also Published As

Publication number Publication date
ES2174054T3 (es) 2002-11-01
BR9607679B8 (pt) 2014-11-18
MX9706661A (es) 1997-11-29
HUP9801414A3 (en) 2001-04-28
AU4724496A (en) 1996-09-23
HUP9801414A2 (hu) 1999-01-28
PL184245B1 (pl) 2002-09-30
US5681827A (en) 1997-10-28
GB9504599D0 (en) 1995-04-26
PT813407E (pt) 2002-10-31
HK1007957A1 (zh) 1999-04-30
DE69621785T2 (de) 2002-11-28
NO973964D0 (no) 1997-08-28
CN1177292A (zh) 1998-03-25
EP0813407B1 (de) 2002-06-12
NO973964L (no) 1997-08-28
AU696480B2 (en) 1998-09-10
JPH11501044A (ja) 1999-01-26
KR19980702689A (ko) 1998-08-05
WO1996027368A1 (en) 1996-09-12
AR004168A1 (es) 1998-11-04
DE69621785D1 (de) 2002-07-18
CN1123337C (zh) 2003-10-08
TR199700891T1 (xx) 1998-02-21
PL322044A1 (en) 1998-01-05
CZ274997A3 (cs) 1998-03-18
BR9607679A (pt) 1998-07-07
NO316207B1 (no) 2003-12-29
CZ289386B6 (cs) 2002-01-16
NZ301749A (en) 1998-05-27
EP0813407A1 (de) 1997-12-29
ZA961517B (en) 1996-09-03

Similar Documents

Publication Publication Date Title
DE69621785D1 (de) Flüssige wässrige arzneimittel, die natriumalginat und kaliumhydrogencarbonat enthalten
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
AU699581B2 (en) Glycinamide derivatives, processes for their preparation and medicines containing them
HUP9801688A3 (en) Acetamide derivatives, process for producing the same, and medicinal composition containing the same
AU5318596A (en) Skin care products containing anti-itching/anti-irritant age nts
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
HUP9603071A3 (en) Purin-6-one derivatives, producing and pharmaceuticals preparations containing them
AR011565A3 (es) Una composicion humectante, liquida y acuosa
HUP9800792A3 (en) Benzylpiperidines and piperazines, their use and pharmaceutical compositions containing the same
HUP9602601A3 (en) Piperidine and piperazine derivatives, medicines containing them as active ingredient and their use
HUP9802552A3 (en) Piperazino derivatives process for their preparation, pharmaceuticals containing the same and their use
PL321003A1 (en) Derivatives of piperasine, drugs containing them, their application and methods of obtaining them
HUP9802422A3 (en) Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them
GB9302720D0 (en) Products in capsule form for use in aqueous solution
DE3784905D1 (de) Gamma-l-glutamyl-l-cysteinethylester und arzneimittel, die dieses als aktives mittel enthalten.
HUP9901685A3 (en) Colchicine derivatives, the use thereof and formulations containing them
EP0823255A4 (de) Sucralfat enthaltendes arzneimittel
HUP9801766A3 (en) 6-carboxamido dihydropyran derivatives, process for producing them and medicaments containing the same
AU1811495A (en) Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation
PL316486A1 (en) Novel sulphonamides, method of obtaining them and therapeutic agent containing them
ITTO940560A0 (it) Testa rullatrice per l'applicazione di capsule di sigillo su bottigliein genere.
DE3874390D1 (de) Carboxystyrol-derivate und arzneimittel, die sie als wirkstoff enthalten.
HUP9801068A2 (hu) 1,2,3,4-Tetrahidro-2-naftil-amin-származékok, ezek előállítása és alkalmazása, valamint ilyen származékokat tartalmazó gyógyászati készítmények
HUP9602977A3 (en) Arylpiperidine and arylpiperazine derivatives and drugs containing the same
IL117078A (en) Substituted benzenesulfonylureas and-thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee